Μετάλλαξη BRCA (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Μετάλλαξη BRCA" in Greek language version.

refsWebsite

Global rank Greek rank

30nih.gov

4^th place

16doi.org

2^nd place

3^rd place

7tools.wmflabs.org

3,290^th place

243^rd place

7wikipedia.org

low place

2cancer.gov

1,684^th place

784^th place

2archive.org

6^th place

5^th place

1cnn.com

28^th place

93^rd place

1ama-assn.org

3,257^th place

2,660^th place

1web.archive.org

1^st place

1jca.gr.jp

low place

1researchgate.net

120^th place

213^th place

1books.google.com

3^rd place

6^th place

1uptodate.com

3,771^st place

3,079^th place

1dnatube.com

low place

1telegraph.co.uk

30^th place

91^st place

ama-assn.org

jama.ama-assn.org

Jeffrey N. Weitzel, Veronica I. Lagos, Carey A. Cullinane, Patricia J. Gambol, Julie O. Culver, Kathleen R. Blazer, Melanie R. Palomares, Katrina J. Lowstuter, Deborah J. MacDonald (2007). «Limited Family Structure and BRCA Gene Mutation Status in Single Cases of Breast Cancer». Journal of the American Medical Association 297 (23): 2587–2595. doi:10.1001/jama.297.23.2587. http://jama.ama-assn.org/content/297/23/2587.full.

archive.org

Morris, Joi L.· Gordon, Ora K. (2010). Positive Results: Making the Best Decisions When You're at High Risk for Breast or Ovarian Cancer. Amherst, N.Y.: Prometheus Books. ISBN 978-1-59102-776-8.
Cui, J; Antoniou, AC; Dite, GS; Southey, MC; Venter, DJ; Easton, DF; Giles, GG; McCredie, MR και άλλοι. (Feb 2001). «After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer». Am J Hum Genet 68 (2): 420–31. doi:10.1086/318187. PMID 11133358. PMC 1235275. https://archive.org/details/sim_american-journal-of-human-genetics_2001-02_68_2/page/420.

books.google.com

Iodice, Simona; Barile, Monica; Rotmensz, Nicole; Feroce, Irene; Bonanni, Bernardo; Radice, Paolo; Bernard, Loris; Maisonneuve, Patrick και άλλοι. (August 2010). «Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis». European Journal of Cancer 46 (12): 2275–2284. doi:10.1016/j.ejca.2010.04.018. PMID 20537530. http://www.researchgate.net/publication/44663020_Oral_contraceptive_use_and_breast_or_ovarian_cancer_risk_in_BRCA12_carriers_a_meta-analysis/file/d912f500eb7c63feb5.pdf.
Lu, Karen H.· Berchuck, Andrew· Kauff, Noah D. (7 Μαΐου 2013). «Hereditary gynecologic cancers». Στο: Barakat, Richard D.· Berchuck, Andrew· Markman, Maurie· Randall, Marcus E. Principles and practice of gynecologic oncology (6th έκδοση). Philadelphia: Lippincott Williams & Wilkins. ISBN 978-1-4698-3148-0.
Isaacs, Claudine· Fletcher, Suzanne W.· Peskin, Beth N. (Μαΐου 2013). Hayes, Daniel F.· Duda, Rosemary B., επιμ. «Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations». Waltham, Mass.: UpToDate. Ανακτήθηκε στις 13 Ιουνίου 2013.
PDQ Cancer Genetics Editorial Board (7 Ιουνίου 2013). «PDQ Genetics of breast and ovarian cancer (Health professional version)». Bethesda, Md.: National Cancer Institute. Ανακτήθηκε στις 13 Ιουνίου 2013.

cancer.gov

«BRCA1 and BRCA2: Cancer Risk and Genetic Testing». National Cancer Institute. 29 Μαΐου 2009.
Iodice, Simona; Barile, Monica; Rotmensz, Nicole; Feroce, Irene; Bonanni, Bernardo; Radice, Paolo; Bernard, Loris; Maisonneuve, Patrick και άλλοι. (August 2010). «Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis». European Journal of Cancer 46 (12): 2275–2284. doi:10.1016/j.ejca.2010.04.018. PMID 20537530. http://www.researchgate.net/publication/44663020_Oral_contraceptive_use_and_breast_or_ovarian_cancer_risk_in_BRCA12_carriers_a_meta-analysis/file/d912f500eb7c63feb5.pdf.
Lu, Karen H.· Berchuck, Andrew· Kauff, Noah D. (7 Μαΐου 2013). «Hereditary gynecologic cancers». Στο: Barakat, Richard D.· Berchuck, Andrew· Markman, Maurie· Randall, Marcus E. Principles and practice of gynecologic oncology (6th έκδοση). Philadelphia: Lippincott Williams & Wilkins. ISBN 978-1-4698-3148-0.
Isaacs, Claudine· Fletcher, Suzanne W.· Peskin, Beth N. (Μαΐου 2013). Hayes, Daniel F.· Duda, Rosemary B., επιμ. «Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations». Waltham, Mass.: UpToDate. Ανακτήθηκε στις 13 Ιουνίου 2013.
PDQ Cancer Genetics Editorial Board (7 Ιουνίου 2013). «PDQ Genetics of breast and ovarian cancer (Health professional version)». Bethesda, Md.: National Cancer Institute. Ανακτήθηκε στις 13 Ιουνίου 2013.

cnn.com

edition.cnn.com

Holly Yan (14 Μαΐου 2013). «What's the gene that led to Angelina Jolie's double mastectomy?». Health. CNN.

dnatube.com

Friedenson B (2007). «The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers». BMC Cancer 7: 15. doi:10.1186/1471-2407-7-152. PMID 17683622. Lay summary – The BRCA1/2 pathway prevents leukemias and lymphomas (Video).

doi.org

dx.doi.org

Jeffrey N. Weitzel, Veronica I. Lagos, Carey A. Cullinane, Patricia J. Gambol, Julie O. Culver, Kathleen R. Blazer, Melanie R. Palomares, Katrina J. Lowstuter, Deborah J. MacDonald (2007). «Limited Family Structure and BRCA Gene Mutation Status in Single Cases of Breast Cancer». Journal of the American Medical Association 297 (23): 2587–2595. doi:10.1001/jama.297.23.2587. http://jama.ama-assn.org/content/297/23/2587.full.
Yoshida K, Miki Y (November 2004). «Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage». Cancer science 95 (11): 866–71. doi:10.1111/j.1349-7006.2004.tb02195.x. PMID 15546503. Αρχειοθετήθηκε από το πρωτότυπο στις 2005-08-20. https://web.archive.org/web/20050820090304/http://www.jca.gr.jp/cs/95/11/866.pdf. Ανακτήθηκε στις 2014-05-29.
Cui, J; Antoniou, AC; Dite, GS; Southey, MC; Venter, DJ; Easton, DF; Giles, GG; McCredie, MR και άλλοι. (Feb 2001). «After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer». Am J Hum Genet 68 (2): 420–31. doi:10.1086/318187. PMID 11133358. PMC 1235275. https://archive.org/details/sim_american-journal-of-human-genetics_2001-02_68_2/page/420.
Greenberg RA (September 2006). «BRCA mutations and childhood cancer». Cancer Biol. Ther. 5 (9): 1103–4. doi:10.4161/cbt.5.9.3370. PMID 17012842.
Chen, S.; Parmigiani, G. (Apr 2007). «Meta-analysis of BRCA1 and BRCA2 penetrance.». J Clin Oncol 25 (11): 1329–33. doi:10.1200/JCO.2006.09.1066. PMID 17416853.
Kurian, AW; Sigal, BM; Plevritis, SK (Jan 2010). «Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.». J Clin Oncol 28 (2): 222–31. doi:10.1200/JCO.2009.22.7991. PMID 19996031.
Iodice, Simona; Barile, Monica; Rotmensz, Nicole; Feroce, Irene; Bonanni, Bernardo; Radice, Paolo; Bernard, Loris; Maisonneuve, Patrick και άλλοι. (August 2010). «Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis». European Journal of Cancer 46 (12): 2275–2284. doi:10.1016/j.ejca.2010.04.018. PMID 20537530. http://www.researchgate.net/publication/44663020_Oral_contraceptive_use_and_breast_or_ovarian_cancer_risk_in_BRCA12_carriers_a_meta-analysis/file/d912f500eb7c63feb5.pdf.
Lu, Karen H.· Berchuck, Andrew· Kauff, Noah D. (7 Μαΐου 2013). «Hereditary gynecologic cancers». Στο: Barakat, Richard D.· Berchuck, Andrew· Markman, Maurie· Randall, Marcus E. Principles and practice of gynecologic oncology (6th έκδοση). Philadelphia: Lippincott Williams & Wilkins. ISBN 978-1-4698-3148-0.
Isaacs, Claudine· Fletcher, Suzanne W.· Peskin, Beth N. (Μαΐου 2013). Hayes, Daniel F.· Duda, Rosemary B., επιμ. «Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations». Waltham, Mass.: UpToDate. Ανακτήθηκε στις 13 Ιουνίου 2013.
PDQ Cancer Genetics Editorial Board (7 Ιουνίου 2013). «PDQ Genetics of breast and ovarian cancer (Health professional version)». Bethesda, Md.: National Cancer Institute. Ανακτήθηκε στις 13 Ιουνίου 2013.
Cibula, David; Zikan, Michal; Dusek, Ladislav; Majek, Ondrej (August 2011). «Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis». Expert Review of Anticancer Therapy 11 (8): 1197–1207. doi:10.1586/era.11.38. PMID 21916573.
Stadler, ZK.; Kauff, ND. (Jan 2010). «Weighing options for cancer risk reduction in carriers of BRCA1 and BRCA2 mutations.». J Clin Oncol 28 (2): 189–91. doi:10.1200/JCO.2009.25.6875. PMID 19996025.
Fishman A (October 2010). «The effects of parity, breastfeeding, and infertility treatment on the risk of hereditary breast and ovarian cancer: a review». Int. J. Gynecol. Cancer 20 (11 Suppl 2): S31–3. doi:10.1111/IGC.0b013e3181f60d4d. PMID 20975359.
King, MC; Marks, JH; Mandell, JB (Oct 2003). «Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.». Science 302 (5645): 643–6. doi:10.1126/science.1088759. PMID 14576434.
Friedenson B (2007). «The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers». BMC Cancer 7: 15. doi:10.1186/1471-2407-7-152. PMID 17683622. Lay summary – The BRCA1/2 pathway prevents leukemias and lymphomas (Video).
Pal T, Keefe D, Sun P, Narod SA (April 2010). «Fertility in women with BRCA mutations: a case-control study». Fertil. Steril. 93 (6): 1805–8. doi:10.1016/j.fertnstert.2008.12.052. PMID 19200971.
Oktay, K; Kim, JY; Barad, D; Babayev, SN (Jan 2010). «Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks.». J Clin Oncol 28 (2): 240–4. doi:10.1200/JCO.2009.24.2057. PMID 19996028.
Moslehi, R; Singh, R; Lessner, L; Friedman, JM (March–April 2010). «Impact of BRCA mutations on female fertility and offspring sex ratio.». Am J Hum Biol 22 (2): 201–5. doi:10.1002/ajhb.20978. PMID 19642207.
Kotsopoulos J, Lubisnki J, Salmena L, et al. (March 2012). «Breastfeeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers». Breast Cancer Res 14 (2): R42. doi:10.1186/bcr3138. PMID 22405187. Lay summary – The Telegraph (29 March 2012).

jca.gr.jp

Yoshida K, Miki Y (November 2004). «Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage». Cancer science 95 (11): 866–71. doi:10.1111/j.1349-7006.2004.tb02195.x. PMID 15546503. Αρχειοθετήθηκε από το πρωτότυπο στις 2005-08-20. https://web.archive.org/web/20050820090304/http://www.jca.gr.jp/cs/95/11/866.pdf. Ανακτήθηκε στις 2014-05-29.

nih.gov

ncbi.nlm.nih.gov

Yoshida K, Miki Y (November 2004). «Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage». Cancer science 95 (11): 866–71. doi:10.1111/j.1349-7006.2004.tb02195.x. PMID 15546503. Αρχειοθετήθηκε από το πρωτότυπο στις 2005-08-20. https://web.archive.org/web/20050820090304/http://www.jca.gr.jp/cs/95/11/866.pdf. Ανακτήθηκε στις 2014-05-29.
Friedenson B (2005). «BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian». MedGenMed 7 (2): 60. PMID 16369438.
Cui, J; Antoniou, AC; Dite, GS; Southey, MC; Venter, DJ; Easton, DF; Giles, GG; McCredie, MR και άλλοι. (Feb 2001). «After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer». Am J Hum Genet 68 (2): 420–31. doi:10.1086/318187. PMID 11133358. PMC 1235275. https://archive.org/details/sim_american-journal-of-human-genetics_2001-02_68_2/page/420.
Greenberg RA (September 2006). «BRCA mutations and childhood cancer». Cancer Biol. Ther. 5 (9): 1103–4. doi:10.4161/cbt.5.9.3370. PMID 17012842.
Chen, S.; Parmigiani, G. (Apr 2007). «Meta-analysis of BRCA1 and BRCA2 penetrance.». J Clin Oncol 25 (11): 1329–33. doi:10.1200/JCO.2006.09.1066. PMID 17416853.
PMID 15996267 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 19232099 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 9652611 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
Kurian, AW; Sigal, BM; Plevritis, SK (Jan 2010). «Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.». J Clin Oncol 28 (2): 222–31. doi:10.1200/JCO.2009.22.7991. PMID 19996031.
PMID 24145348 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
Iodice, Simona; Barile, Monica; Rotmensz, Nicole; Feroce, Irene; Bonanni, Bernardo; Radice, Paolo; Bernard, Loris; Maisonneuve, Patrick και άλλοι. (August 2010). «Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis». European Journal of Cancer 46 (12): 2275–2284. doi:10.1016/j.ejca.2010.04.018. PMID 20537530. http://www.researchgate.net/publication/44663020_Oral_contraceptive_use_and_breast_or_ovarian_cancer_risk_in_BRCA12_carriers_a_meta-analysis/file/d912f500eb7c63feb5.pdf.
Lu, Karen H.· Berchuck, Andrew· Kauff, Noah D. (7 Μαΐου 2013). «Hereditary gynecologic cancers». Στο: Barakat, Richard D.· Berchuck, Andrew· Markman, Maurie· Randall, Marcus E. Principles and practice of gynecologic oncology (6th έκδοση). Philadelphia: Lippincott Williams & Wilkins. ISBN 978-1-4698-3148-0.
Isaacs, Claudine· Fletcher, Suzanne W.· Peskin, Beth N. (Μαΐου 2013). Hayes, Daniel F.· Duda, Rosemary B., επιμ. «Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations». Waltham, Mass.: UpToDate. Ανακτήθηκε στις 13 Ιουνίου 2013.
PDQ Cancer Genetics Editorial Board (7 Ιουνίου 2013). «PDQ Genetics of breast and ovarian cancer (Health professional version)». Bethesda, Md.: National Cancer Institute. Ανακτήθηκε στις 13 Ιουνίου 2013.
Cibula, David; Zikan, Michal; Dusek, Ladislav; Majek, Ondrej (August 2011). «Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis». Expert Review of Anticancer Therapy 11 (8): 1197–1207. doi:10.1586/era.11.38. PMID 21916573.
PMID 21123638 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 23232752 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
Stadler, ZK.; Kauff, ND. (Jan 2010). «Weighing options for cancer risk reduction in carriers of BRCA1 and BRCA2 mutations.». J Clin Oncol 28 (2): 189–91. doi:10.1200/JCO.2009.25.6875. PMID 19996025.
Fishman A (October 2010). «The effects of parity, breastfeeding, and infertility treatment on the risk of hereditary breast and ovarian cancer: a review». Int. J. Gynecol. Cancer 20 (11 Suppl 2): S31–3. doi:10.1111/IGC.0b013e3181f60d4d. PMID 20975359.
King, MC; Marks, JH; Mandell, JB (Oct 2003). «Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.». Science 302 (5645): 643–6. doi:10.1126/science.1088759. PMID 14576434.
Friedenson B (2007). «The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers». BMC Cancer 7: 15. doi:10.1186/1471-2407-7-152. PMID 17683622. Lay summary – The BRCA1/2 pathway prevents leukemias and lymphomas (Video).
Pal T, Keefe D, Sun P, Narod SA (April 2010). «Fertility in women with BRCA mutations: a case-control study». Fertil. Steril. 93 (6): 1805–8. doi:10.1016/j.fertnstert.2008.12.052. PMID 19200971.
Oktay, K; Kim, JY; Barad, D; Babayev, SN (Jan 2010). «Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks.». J Clin Oncol 28 (2): 240–4. doi:10.1200/JCO.2009.24.2057. PMID 19996028.
Moslehi, R; Singh, R; Lessner, L; Friedman, JM (March–April 2010). «Impact of BRCA mutations on female fertility and offspring sex ratio.». Am J Hum Biol 22 (2): 201–5. doi:10.1002/ajhb.20978. PMID 19642207.
Kotsopoulos J, Lubisnki J, Salmena L, et al. (March 2012). «Breastfeeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers». Breast Cancer Res 14 (2): R42. doi:10.1186/bcr3138. PMID 22405187. Lay summary – The Telegraph (29 March 2012).
PMID 16867211 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

pubmedcentral.nih.gov

Friedenson B (2005). «BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian». MedGenMed 7 (2): 60. PMID 16369438.
Cui, J; Antoniou, AC; Dite, GS; Southey, MC; Venter, DJ; Easton, DF; Giles, GG; McCredie, MR και άλλοι. (Feb 2001). «After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer». Am J Hum Genet 68 (2): 420–31. doi:10.1086/318187. PMID 11133358. PMC 1235275. https://archive.org/details/sim_american-journal-of-human-genetics_2001-02_68_2/page/420.
Greenberg RA (September 2006). «BRCA mutations and childhood cancer». Cancer Biol. Ther. 5 (9): 1103–4. doi:10.4161/cbt.5.9.3370. PMID 17012842.
Chen, S.; Parmigiani, G. (Apr 2007). «Meta-analysis of BRCA1 and BRCA2 penetrance.». J Clin Oncol 25 (11): 1329–33. doi:10.1200/JCO.2006.09.1066. PMID 17416853.
Kurian, AW; Sigal, BM; Plevritis, SK (Jan 2010). «Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.». J Clin Oncol 28 (2): 222–31. doi:10.1200/JCO.2009.22.7991. PMID 19996031.
Friedenson B (2007). «The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers». BMC Cancer 7: 15. doi:10.1186/1471-2407-7-152. PMID 17683622. Lay summary – The BRCA1/2 pathway prevents leukemias and lymphomas (Video).
Oktay, K; Kim, JY; Barad, D; Babayev, SN (Jan 2010). «Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks.». J Clin Oncol 28 (2): 240–4. doi:10.1200/JCO.2009.24.2057. PMID 19996028.

researchgate.net

Iodice, Simona; Barile, Monica; Rotmensz, Nicole; Feroce, Irene; Bonanni, Bernardo; Radice, Paolo; Bernard, Loris; Maisonneuve, Patrick και άλλοι. (August 2010). «Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis». European Journal of Cancer 46 (12): 2275–2284. doi:10.1016/j.ejca.2010.04.018. PMID 20537530. http://www.researchgate.net/publication/44663020_Oral_contraceptive_use_and_breast_or_ovarian_cancer_risk_in_BRCA12_carriers_a_meta-analysis/file/d912f500eb7c63feb5.pdf.
Lu, Karen H.· Berchuck, Andrew· Kauff, Noah D. (7 Μαΐου 2013). «Hereditary gynecologic cancers». Στο: Barakat, Richard D.· Berchuck, Andrew· Markman, Maurie· Randall, Marcus E. Principles and practice of gynecologic oncology (6th έκδοση). Philadelphia: Lippincott Williams & Wilkins. ISBN 978-1-4698-3148-0.
Isaacs, Claudine· Fletcher, Suzanne W.· Peskin, Beth N. (Μαΐου 2013). Hayes, Daniel F.· Duda, Rosemary B., επιμ. «Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations». Waltham, Mass.: UpToDate. Ανακτήθηκε στις 13 Ιουνίου 2013.
PDQ Cancer Genetics Editorial Board (7 Ιουνίου 2013). «PDQ Genetics of breast and ovarian cancer (Health professional version)». Bethesda, Md.: National Cancer Institute. Ανακτήθηκε στις 13 Ιουνίου 2013.

telegraph.co.uk

Kotsopoulos J, Lubisnki J, Salmena L, et al. (March 2012). «Breastfeeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers». Breast Cancer Res 14 (2): R42. doi:10.1186/bcr3138. PMID 22405187. Lay summary – The Telegraph (29 March 2012).

tools.wmflabs.org

PMID 15996267 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 19232099 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 9652611 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 24145348 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 21123638 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 23232752 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 16867211 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

uptodate.com

Iodice, Simona; Barile, Monica; Rotmensz, Nicole; Feroce, Irene; Bonanni, Bernardo; Radice, Paolo; Bernard, Loris; Maisonneuve, Patrick και άλλοι. (August 2010). «Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis». European Journal of Cancer 46 (12): 2275–2284. doi:10.1016/j.ejca.2010.04.018. PMID 20537530. http://www.researchgate.net/publication/44663020_Oral_contraceptive_use_and_breast_or_ovarian_cancer_risk_in_BRCA12_carriers_a_meta-analysis/file/d912f500eb7c63feb5.pdf.
Lu, Karen H.· Berchuck, Andrew· Kauff, Noah D. (7 Μαΐου 2013). «Hereditary gynecologic cancers». Στο: Barakat, Richard D.· Berchuck, Andrew· Markman, Maurie· Randall, Marcus E. Principles and practice of gynecologic oncology (6th έκδοση). Philadelphia: Lippincott Williams & Wilkins. ISBN 978-1-4698-3148-0.
Isaacs, Claudine· Fletcher, Suzanne W.· Peskin, Beth N. (Μαΐου 2013). Hayes, Daniel F.· Duda, Rosemary B., επιμ. «Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations». Waltham, Mass.: UpToDate. Ανακτήθηκε στις 13 Ιουνίου 2013.
PDQ Cancer Genetics Editorial Board (7 Ιουνίου 2013). «PDQ Genetics of breast and ovarian cancer (Health professional version)». Bethesda, Md.: National Cancer Institute. Ανακτήθηκε στις 13 Ιουνίου 2013.

web.archive.org

Yoshida K, Miki Y (November 2004). «Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage». Cancer science 95 (11): 866–71. doi:10.1111/j.1349-7006.2004.tb02195.x. PMID 15546503. Αρχειοθετήθηκε από το πρωτότυπο στις 2005-08-20. https://web.archive.org/web/20050820090304/http://www.jca.gr.jp/cs/95/11/866.pdf. Ανακτήθηκε στις 2014-05-29.

wikipedia.org

en.wikipedia.org

PMID 15996267 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 19232099 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 9652611 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 24145348 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 21123638 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 23232752 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
PMID 16867211 (PubMed)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand